Integrin-Mediated Macrophage Adhesion Promotes Lymphovascular Dissemination in Breast Cancer
Rachel Evans,
Fabian Flores-Borja,
Sina Nassiri,
Elena Miranda,
Katherine Lawler,
Anita Grigoriadis,
James Monypenny,
Cheryl Gillet,
Julie Owen,
Peter Gordon,
Victoria Male,
Anthony Cheung,
Farzana Noor,
Paul Barber,
Rebecca Marlow,
Erika Francesch-Domenech,
Gilbert Fruhwirth,
Mario Squadrito,
Borivoj Vojnovic,
Andrew Tutt,
Frederic Festy,
Michele De Palma,
Tony Ng
Affiliations
Rachel Evans
Richard Dimbleby Department of Cancer Research, Randall Division & Division of Cancer Studies, Kings College London, London, UK; Corresponding author
Fabian Flores-Borja
Breast Cancer Now Research Unit, King’s College London, Guy’s Hospital, London, UK
Sina Nassiri
Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
Elena Miranda
Pathology Core Facility, University College London Cancer Institute, London, UK
Katherine Lawler
Richard Dimbleby Department of Cancer Research, Randall Division & Division of Cancer Studies, Kings College London, London, UK; Institute for Mathematical and Molecular Biomedicine, King’s College London, London, UK
Anita Grigoriadis
Breast Cancer Now Research Unit, King’s College London, Guy’s Hospital, London, UK
James Monypenny
Richard Dimbleby Department of Cancer Research, Randall Division & Division of Cancer Studies, Kings College London, London, UK
Cheryl Gillet
King’s Health Partners Cancer Biobank, King’s College London, London, UK; Research Oncology, Division of Cancer Studies, Guy’s Hospital, King’s College London, London, UK
Julie Owen
King’s Health Partners Cancer Biobank, King’s College London, London, UK; Research Oncology, Division of Cancer Studies, Guy’s Hospital, King’s College London, London, UK
Peter Gordon
Breast Cancer Now Research Unit, King’s College London, Guy’s Hospital, London, UK
Victoria Male
Breast Cancer Now Research Unit, King’s College London, Guy’s Hospital, London, UK
Anthony Cheung
Breast Cancer Now Research Unit, King’s College London, Guy’s Hospital, London, UK
Farzana Noor
Breast Cancer Now Research Unit, King’s College London, Guy’s Hospital, London, UK
Paul Barber
Richard Dimbleby Department of Cancer Research, Randall Division & Division of Cancer Studies, Kings College London, London, UK; UCL Cancer Institute, University College London, London, UK
Rebecca Marlow
Breast Cancer Now Research Unit, King’s College London, Guy’s Hospital, London, UK
Erika Francesch-Domenech
Breast Cancer Now Research Unit, King’s College London, Guy’s Hospital, London, UK
Gilbert Fruhwirth
Division of Imaging Sciences and Biomedical Engineering, King’s College London, London, UK
Mario Squadrito
Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
Borivoj Vojnovic
Department of Oncology, Cancer Research UK and Medical Research Council, Oxford Institute for Radiation Oncology, University of Oxford, UK
Andrew Tutt
Breast Cancer Now Research Unit, King’s College London, Guy’s Hospital, London, UK
Frederic Festy
Tissue Engineering and Biophotonics, King’s College London, London, UK
Michele De Palma
Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
Tony Ng
Richard Dimbleby Department of Cancer Research, Randall Division & Division of Cancer Studies, Kings College London, London, UK; Breast Cancer Now Research Unit, King’s College London, Guy’s Hospital, London, UK; UCL Cancer Institute, University College London, London, UK; Corresponding author
Summary: Lymphatic vasculature is crucial for metastasis in triple-negative breast cancer (TNBC); however, cellular and molecular drivers controlling lymphovascular metastasis are poorly understood. We define a macrophage-dependent signaling cascade that facilitates metastasis through lymphovascular remodeling. TNBC cells instigate mRNA changes in macrophages, resulting in β4 integrin-dependent adhesion to the lymphovasculature. β4 integrin retains macrophages proximal to lymphatic endothelial cells (LECs), where release of TGF-β1 drives LEC contraction via RhoA activation. Macrophages promote gross architectural changes to lymphovasculature by increasing dilation, hyperpermeability, and disorganization. TGF-β1 drives β4 integrin clustering at the macrophage plasma membrane, further promoting macrophage adhesion and demonstrating the dual functionality of TGF-β1 signaling in this context. β4 integrin-expressing macrophages were identified in human breast tumors, and a combination of vascular-remodeling macrophage gene signature and TGF-β signaling scores correlates with metastasis. We postulate that future clinical strategies for patients with TNBC should target crosstalk between β4 integrin and TGF-β1. : Breast cancer metastasis through lymphatic vessels is associated with poor prognosis. Evans et al. describe β4 integrin-expressing macrophages that regulate lymphatic vessel structure in breast cancer. Macrophage-released TGF-β1 drives lymphatic cell contraction via RhoA activation, culminating in lymphatic hyperpermeability. This study defines a signaling cascade that could be targeted therapeutically. Keywords: lymphovasculature, macrophages, cancer, remodeling, adhesion, contraction, β4 integrin, TGF-β1, RhoA